Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 20
Selected: 0
NCT IDTitle
NCT02224820Phase II Study, Evaluation of Safety and Efficacy of IdeS in Chronic Kidney Disease
NCT05753930Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
NCT03943589A Study of Imlifidase in Patients With Guillain-Barré Syndrome
NCT05679401A Study With Imlifidase in Anti-GBM Disease
NCT04711850An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR
NCT05049850A Study to Investigate DSA Rebound in Patients Treated with Imlifidase Prior to Transplantation
NCT02426684Ides in Highly Sensitized (HS) Patients Awaiting Kidney Transplantation
NCT05714514Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys
NCT06241950A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Imlifidase Infusion in Participants With Duchenne Muscular Dystrophy (DMD) Determined to Have Pre-existing Antibodies to Recombinant Adeno-Associated Virus Serotype (rAAVrh74)
NCT05937750A Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation and a Non-comparative Transplanted Patient Group
NCT05369975Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts
NCT02854059IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients
NCT03611621A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation
NCT02790437A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
NCT03157037Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease
NCT01802697Safety Study on IdeS in Healthy Volounteers
NCT06518005Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome
NCT03897205An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients
NCT04935177Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx
NCT02475551Study to Evaluate the Safety, Tolerability, Efficacy and PK of IdeS in Kidney Transplantation